Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

NCT00067041 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Vascular Disease

Interventions

DRUG: Remodulin (treprostinil sodium) Injection

Sponsor

United Therapeutics